488 related articles for article (PubMed ID: 27063276)
1. Extrahepatic Complications of Nonalcoholic Fatty Liver Disease.
Chacko KR; Reinus J
Clin Liver Dis; 2016 May; 20(2):387-401. PubMed ID: 27063276
[TBL] [Abstract][Full Text] [Related]
2. Systemic Complications of Nonalcoholic Fatty Liver Disease: When the Liver Is Not an Innocent Bystander.
Vanni E; Marengo A; Mezzabotta L; Bugianesi E
Semin Liver Dis; 2015 Aug; 35(3):236-49. PubMed ID: 26378641
[TBL] [Abstract][Full Text] [Related]
3. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases.
Adams LA; Anstee QM; Tilg H; Targher G
Gut; 2017 Jun; 66(6):1138-1153. PubMed ID: 28314735
[TBL] [Abstract][Full Text] [Related]
4. Nonalcoholic fatty liver disease as a multi-systemic disease.
Fotbolcu H; Zorlu E
World J Gastroenterol; 2016 Apr; 22(16):4079-90. PubMed ID: 27122660
[TBL] [Abstract][Full Text] [Related]
5. Nonalcoholic fatty liver disease - A multisystem disease?
Mikolasevic I; Milic S; Turk Wensveen T; Grgic I; Jakopcic I; Stimac D; Wensveen F; Orlic L
World J Gastroenterol; 2016 Nov; 22(43):9488-9505. PubMed ID: 27920470
[TBL] [Abstract][Full Text] [Related]
6. Extrahepatic complications of non-alcoholic fatty liver disease: Its impact beyond the liver.
Velarde-Ruiz Velasco JA; García-Jiménez ES; García-Zermeño KR; Morel-Cerda EC; Aldana-Ledesma JM; Castro-Narro GE; Cerpa-Cruz S; Tapia-Calderón DK; Mercado-Jauregui LA; Contreras-Omaña R
Rev Gastroenterol Mex (Engl Ed); 2019; 84(4):472-481. PubMed ID: 31488310
[TBL] [Abstract][Full Text] [Related]
7. Nonalcoholic Fatty Liver Disease and Liver Transplantation.
Pham T; Dick TB; Charlton MR
Clin Liver Dis; 2016 May; 20(2):403-17. PubMed ID: 27063277
[TBL] [Abstract][Full Text] [Related]
8. [Non-alcoholic fatty liver disease, as a component of the metabolic syndrome, and its causal correlations with other extrahepatic diseases].
Halmos T; Suba I
Orv Hetil; 2017 Dec; 158(52):2051-2061. PubMed ID: 29285942
[TBL] [Abstract][Full Text] [Related]
9. Evaluation and management of extrahepatic manifestations of nonalcoholic fatty liver disease.
Wijarnpreecha K; Aby ES; Ahmed A; Kim D
Clin Mol Hepatol; 2021 Apr; 27(2):221-235. PubMed ID: 33317243
[TBL] [Abstract][Full Text] [Related]
10. NAFLD and Extra-Hepatic Comorbidities: Current Evidence on a Multi-Organ Metabolic Syndrome.
Rosato V; Masarone M; Dallio M; Federico A; Aglitti A; Persico M
Int J Environ Res Public Health; 2019 Sep; 16(18):. PubMed ID: 31540048
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update.
Athyros VG; Tziomalos K; Katsiki N; Doumas M; Karagiannis A; Mikhailidis DP
World J Gastroenterol; 2015 Jun; 21(22):6820-34. PubMed ID: 26078558
[TBL] [Abstract][Full Text] [Related]
12. Nonalcoholic fatty liver disease and non-liver comorbidities.
Manikat R; Nguyen MH
Clin Mol Hepatol; 2023 Feb; 29(Suppl):s86-s102. PubMed ID: 36603574
[TBL] [Abstract][Full Text] [Related]
13. Understanding the association between developing a fatty liver and subsequent cardio-metabolic complications.
Miele L; Targher G
Expert Rev Gastroenterol Hepatol; 2015; 9(10):1243-5. PubMed ID: 26224399
[TBL] [Abstract][Full Text] [Related]
14. Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease.
Li AA; Ahmed A; Kim D
Gut Liver; 2020 Mar; 14(2):168-178. PubMed ID: 31195434
[TBL] [Abstract][Full Text] [Related]
15. Association of MAFLD With Diabetes, Chronic Kidney Disease, and Cardiovascular Disease: A 4.6-Year Cohort Study in China.
Liang Y; Chen H; Liu Y; Hou X; Wei L; Bao Y; Yang C; Zong G; Wu J; Jia W
J Clin Endocrinol Metab; 2022 Jan; 107(1):88-97. PubMed ID: 34508601
[TBL] [Abstract][Full Text] [Related]
16. Nonalcoholic Fatty Liver Disease in Children: Hepatic and Extrahepatic Complications.
Selvakumar PKC; Kabbany MN; Nobili V; Alkhouri N
Pediatr Clin North Am; 2017 Jun; 64(3):659-675. PubMed ID: 28502444
[TBL] [Abstract][Full Text] [Related]
17. Extrahepatic complications of nonalcoholic fatty liver disease.
Armstrong MJ; Adams LA; Canbay A; Syn WK
Hepatology; 2014 Mar; 59(3):1174-97. PubMed ID: 24002776
[TBL] [Abstract][Full Text] [Related]
18. Review of nonalcoholic fatty liver disease in women with polycystic ovary syndrome.
Kelley CE; Brown AJ; Diehl AM; Setji TL
World J Gastroenterol; 2014 Oct; 20(39):14172-84. PubMed ID: 25339805
[TBL] [Abstract][Full Text] [Related]
19. NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk.
Ballestri S; Nascimbeni F; Baldelli E; Marrazzo A; Romagnoli D; Lonardo A
Adv Ther; 2017 Jun; 34(6):1291-1326. PubMed ID: 28526997
[TBL] [Abstract][Full Text] [Related]
20. Synergistic increase in cardiovascular risk in diabetes mellitus with nonalcoholic fatty liver disease: a meta-analysis.
Zhou YY; Zhou XD; Wu SJ; Hu XQ; Tang B; Poucke SV; Pan XY; Wu WJ; Gu XM; Fu SW; Zheng MH
Eur J Gastroenterol Hepatol; 2018 Jun; 30(6):631-636. PubMed ID: 29351115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
